BR112014029801A2 - composições e métodos de reconstrução óssea biofotônica - Google Patents

composições e métodos de reconstrução óssea biofotônica

Info

Publication number
BR112014029801A2
BR112014029801A2 BR112014029801A BR112014029801A BR112014029801A2 BR 112014029801 A2 BR112014029801 A2 BR 112014029801A2 BR 112014029801 A BR112014029801 A BR 112014029801A BR 112014029801 A BR112014029801 A BR 112014029801A BR 112014029801 A2 BR112014029801 A2 BR 112014029801A2
Authority
BR
Brazil
Prior art keywords
biophotonic
methods
compositions
bone reconstruction
photoactivator
Prior art date
Application number
BR112014029801A
Other languages
English (en)
Inventor
Loupis Nikolaos
Piergallini Remigio
Original Assignee
Klox Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klox Tech Inc filed Critical Klox Tech Inc
Publication of BR112014029801A2 publication Critical patent/BR112014029801A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
    • A61K6/838—Phosphorus compounds, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L24/0073—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
    • A61L24/0084—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix containing fillers of phosphorus-containing inorganic compounds, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/32—Phosphorus-containing compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0041—Optical brightening agents, organic pigments
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/15—Heterocyclic compounds having oxygen in the ring
    • C08K5/151—Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
    • C08K5/1545—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/442—Colorants, dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662—Visible light
    • A61N2005/0663—Coloured light
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/32—Phosphorus-containing compounds
    • C08K2003/321—Phosphates
    • C08K2003/325—Calcium, strontium or barium phosphate

Abstract

resumo "composições e métodos de reconstrução óssea biofotônica". a presente invenção refere-se a composições biofotônicas que compreendem um fotoativador, um mineral de fosfato de cálcio, ácido hialurônico e, opcionalmente, glucosamina. a dita composição tem utilidade no aumento, reparação e/ou regeneração do osso, quando usada em conjunto com luz actínica de um comprimento de onda absorvido pelo fotoativador.
BR112014029801A 2012-05-30 2013-05-30 composições e métodos de reconstrução óssea biofotônica BR112014029801A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261653101P 2012-05-30 2012-05-30
US201361777894P 2013-03-12 2013-03-12
PCT/CA2013/000532 WO2013177686A1 (en) 2012-05-30 2013-05-30 Compositions and methods for biophotonic bone reconstruction

Publications (1)

Publication Number Publication Date
BR112014029801A2 true BR112014029801A2 (pt) 2017-06-27

Family

ID=49672237

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014029801A BR112014029801A2 (pt) 2012-05-30 2013-05-30 composições e métodos de reconstrução óssea biofotônica

Country Status (17)

Country Link
US (1) US11426463B2 (pt)
EP (1) EP2854853B1 (pt)
JP (1) JP2015519134A (pt)
KR (1) KR20150023294A (pt)
CN (1) CN104394888A (pt)
AU (1) AU2013270353A1 (pt)
BR (1) BR112014029801A2 (pt)
CA (1) CA2873068A1 (pt)
HK (1) HK1207300A1 (pt)
IL (1) IL235687A0 (pt)
IN (1) IN2014DN09950A (pt)
MX (1) MX2014014458A (pt)
NZ (1) NZ701667A (pt)
RU (1) RU2014147975A (pt)
SG (1) SG11201407276RA (pt)
WO (1) WO2013177686A1 (pt)
ZA (1) ZA201408483B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9834740B2 (en) * 2014-01-24 2017-12-05 The Procter & Gamble Company Photoactivators
AR099941A1 (es) * 2014-04-01 2016-08-31 Klox Tech Inc Composiciones para relleno de tejido y métodos de uso
JP6158885B2 (ja) * 2015-10-14 2017-07-05 三菱電機株式会社 光源ユニット及び照明装置

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1259090B (it) 1992-04-17 1996-03-11 Fidia Spa Biomaterialli per protesi d'osso
GB9721585D0 (en) 1997-10-10 1997-12-10 Geistlich Soehne Ag Chemical product
DE60020526T2 (de) * 1999-02-04 2006-05-11 SDGI Holdings, Inc., Wilmington Osteogene pastenzusammensetzungen und ihre verwendung
CN1172681C (zh) 1999-08-18 2004-10-27 凌沛学 透明质酸口服美肤保健品
US8876532B2 (en) 2002-07-31 2014-11-04 Dentsply International Inc. Bone repair putty
US7842300B2 (en) 2002-07-31 2010-11-30 Dentsply International, Inc. Bone repair putty
AU2003287526A1 (en) 2002-11-06 2004-06-03 Protein-stabilized liposomal formulations of pharmaceutical agents
CN101052360B (zh) 2003-09-23 2012-05-16 奥索康公司 可吸收的植入体和它们用于止血和治疗骨缺损的方法
ITPD20030286A1 (it) 2003-11-27 2005-05-28 Fidia Advanced Biopolymers Srl Strutture composite multistrato contenenti acido ialuronico
WO2007027092A2 (en) 2005-09-02 2007-03-08 Campina Nederland Holding B.V. Oral composition for moisturising skin
US9132208B2 (en) * 2008-08-07 2015-09-15 Lifenet Health Composition for a tissue repair implant and methods of making the same
WO2007079053A2 (en) 2005-12-28 2007-07-12 Dentsply International Inc. Light-curable bone growth material for treating dental bone defects
US8999933B2 (en) 2006-01-18 2015-04-07 Biolitec Pharma Marketing Ltd Photodynamic cosmetic procedure and healing method
JP2007197371A (ja) 2006-01-26 2007-08-09 Yaizu Suisankagaku Industry Co Ltd 美肌促進剤及び美容健康食品
EP2114474A4 (en) 2006-12-08 2013-07-31 Graftoss Ltd MEDICAL PREPARATION
CA2677498C (en) * 2007-02-05 2016-05-17 Carbylan Biosurgery, Inc. Polymer formulations for delivery of bioactive agents
WO2009018555A1 (en) 2007-08-01 2009-02-05 The Johns Hopkins University Photoinitiated tissue filler
CN102065914A (zh) * 2008-04-15 2011-05-18 埃泰克斯公司 使用磷酸钙组合的骨接合剂的脊椎骨最小侵入性治疗(mitv)
DK2453922T3 (en) * 2009-07-17 2018-01-02 Klox Tech Inc ANTIBACTERIAL ORAL COMPOSITION

Also Published As

Publication number Publication date
ZA201408483B (en) 2015-12-23
NZ701667A (en) 2017-05-26
CN104394888A (zh) 2015-03-04
JP2015519134A (ja) 2015-07-09
US11426463B2 (en) 2022-08-30
MX2014014458A (es) 2015-08-14
IN2014DN09950A (pt) 2015-08-14
HK1207300A1 (en) 2016-01-29
CA2873068A1 (en) 2013-12-05
EP2854853B1 (en) 2019-08-21
EP2854853A1 (en) 2015-04-08
KR20150023294A (ko) 2015-03-05
AU2013270353A1 (en) 2014-11-27
RU2014147975A (ru) 2016-07-20
EP2854853A4 (en) 2016-01-13
IL235687A0 (en) 2015-01-29
SG11201407276RA (en) 2015-03-30
WO2013177686A1 (en) 2013-12-05
US20150119789A1 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
BR112015009162A2 (pt) Gel de ácido hialurônico reticulado, processo para preparar um gel de ácido hialurônico reticulado, composições dermatológicas, kit e uso de um gel de ácido hialurônico reticulado
EP4282922A3 (en) Additive for imparting ultraviolet absorptivity and/or high refractive index to matrix, and resin member using same
BR112015008327A2 (pt) aditivo de limpeza e método de limpeza usando o mesmo
BR112014026740A2 (pt) anticorpo, composição, métodos para tratar um mamífero e para fornecer um anticorpo com adcc realçada, e, uso de um anticorpo
BR112015006119A2 (pt) métodos de triagem para micro-organismos que transmitem propriedades benéficas para plantas
BR112015000892A2 (pt) processo de preparar ácido acrílico
AR090465A1 (es) Formas solidas de un profarmaco de nucleotidos de tiofosforamidato
BR112014004929A2 (pt) conversão de unidades de alquilação de hf para processos de alquilação catalisada por líquido iônico
BR112015020478A2 (pt) composição e processo para alisamento semipermanente dos cabelos
BR112013031307A2 (pt) métodos para tratamento de material lignocelulósico
BR112015005653A2 (pt) Método de promover o desenvolvimento de oócitos maduros e de aumentar a polimerização de actina em tecido ovariano, e uso de um agente que perturba a sinalização na trajetória hippo, ou um agente que age a jusante da sinalização hippo perturbada
BR112015008912A2 (pt) composições solidificáveis compreendendo volastonita e pedra-pomes e métodos de uso
BR112015016212A2 (pt) limpador de forno em dose unitária de tablete sólido
BR112018009609A8 (pt) composições dentifrícias com absorção melhorada de fluoreto
BR112014009287A8 (pt) composições de policarbonato estabilizadas com misturas de ácido silícico e um ácido inorgânico
BR112017010669A2 (pt) composição, método para reduzir o número de patógenos sobre uma superfície e método para reduzir o número de patógenos em um volume de um produto alimentício
BR112016009482A8 (pt) composição de revestimento, uso de uma composição de revestimento, processo para preparação de adutos e método para cura de uma composição de revestimento
BR112012026659A2 (pt) composto para desinfecção de superfícies.
BR112015032393A2 (pt) processo para a preparação estereosseletiva de uma pirazol-carboxamida
BR112014015976A2 (pt) composição e artigo
BR112014029801A2 (pt) composições e métodos de reconstrução óssea biofotônica
BR112015011764A2 (pt) composições de baixo teor de sal de sódio e métodos de produção e utilização
BR112015029954A2 (pt) composição e processo para tratar as fibras queratínicas
BR112013028222A2 (pt) Composição polimérica para dispositivos elétricos
BR112012028945A2 (pt) uso de marcadores específicos do gene brown midrib-3 no milho para a incorporação de traços

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2517 DE 02-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.